Announcement: OPTIMIZING ANTIINFLAMMATORY RELIEVER THERAPY: a FUNDAMENTAL CHANGE in APPROACH to TREATING ASTHMA

Program Objectives

Upon completion of this module participants will be better able to:

Module 1: ANTI-INFLAMMATORY RELIEVER REDUCES EXACERBATIONS

• Describe the latest asthma treatment recommendations from the Global,

Initiative for Asthma (GINA) and the Canadian Thoracic Society (CTS);

• Discuss why over-reliance on short-acting beta-agonists (SABA) increases

risk of exacerbations and worsening asthma.

• Discuss recent evidence on anti-inflammatory reliever reducing asthma

exacerbations.

• Identify strategies to transition patients from SABA as a reliever to

anti-inflammatory reliever.

Module 2: PERCEPTION OF ASTHMA CONTROL

• Identify two treatment paradoxes that may impact patients’ acceptance

of asthma maintenance therapy;

• Describe how patient and physician perception of asthma control may

differ and how this may impact asthma management;

• Review asthma management in patients with asthma and COVID-19.